Table 1 Patient characteristics for all 98 UC samples included in the study
From: Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma
Patient characteristics | Subgroup 1 | Subgroup 2 | Subgroup 3 | Subgroup 4 | ||
|---|---|---|---|---|---|---|
Total | N | N | N | N | ||
Samples | N | 98 | 18 | 21 | 24 | 35 |
Gender | Male | 69 | 12 | 16 | 19 | 22 |
Female | 29 | 6 | 5 | 5 | 13 | |
WHO 1999 Stage | Ta | 45 | 16 | 14 | 5 | 10 |
T1 | 25 | 2 | 5 | 9 | 9 | |
MI | 27 | 0 | 1 | 10 | 16 | |
Tx | 1 | 0 | 1 | 0 | 0 | |
WHO 1999 Grade | Grade 1 | 19 | 11 | 5 | 1 | 2 |
Grade 2 | 32 | 7 | 11 | 4 | 10 | |
Grade 3 | 47 | 0 | 5 | 19 | 23 | |
TP53 mutation | Mutation | 29 | 0 | 4 | 11 | 14 |
Wild type | 69 | 18 | 17 | 13 | 21 | |
FGFR3 mutation | Mutation | 34 | 12 | 11 | 1 | 10 |
Wild type | 64 | 6 | 10 | 23 | 25 | |
Lund subtype | Urobasal A | 44 | 18 | 15 | 2 | 9 |
Urobasal B | 12 | 0 | 5 | 2 | 5 | |
Genom Unst | 29 | 0 | 0 | 17 | 12 | |
SCC-like | 13 | 0 | 1 | 3 | 9 | |
Lauss epitype | A | 17 | 9 | 6 | 0 | 2 |
B | 9 | 1 | 1 | 0 | 7 | |
C | 17 | 0 | 1 | 11 | 5 | |
D | 7 | 0 | 1 | 0 | 6 | |
NAa | 48 | 8 | 12 | 13 | 15 | |
Age (years) | Median | 71.7 | 68.5 | 70.3 | 70.6 | 75.4 |
Range | (43.5-94.8) | (43.9-84.3) | (49.7-93.0) | (59.0-94.8) | (43.5-93.5) |